Methods 36 patients with chronic severe hepatitis B were randomly divided into 2 groups.
方法36例慢性重型乙型肝炎患者随机分为2组。
Objective: To investigate the effects of colon herbal dialysis in patients with chronic severe hepatitis b.
目的：观察中药结肠透析疗法对慢性重型肝炎的临床效果。
Methods: 70 patients with chronic severe hepatitis B were divided at random into therapeutic group and control group.
方法：70例慢性重型肝炎患者，随机分成治疗组及对照组。
To observe the clinical effect and adverse effect of foscarnet sodium in treating patients with chronic severe hepatitis B.
目的探讨膦甲酸钠治疗慢性重型乙型肝炎的疗效及其不良反应。
Objective To evaluate the treatment of plasma exchange(PE) in patients with chronic severe hepatitis based on prothrombin activity(PTA).
目的探讨根据凝血酶原活动度（PTA）预测重型肝炎高胆红素血症行血浆置换的临床疗效。
Objective To discuss the clinical effect of artificial liver support system in treating patients with chronic severe hepatitis and the safety.
目的探讨人工肝支持治疗对慢性重型肝炎患者的临床效果及安全性。
Objective To investigate changes in intestinal microflora in patients with chronic severe hepatitis (CSH), and their role in this life-threatening disease.
目的研究慢性重型肝炎患者肠道菌群的变化及其在这种重危疾病的发病过程中的作用。
Conclusion Intestinal flora in patients with chronic severe hepatitis were severely disturbed and gut mircobiological colonization resistance was impaired.
结论慢性重型肝炎患者肠道菌群严重失调，肠道定植抗力严重受损。
Conclusions: the plasma exchange is a kind of effective artificial liver support therapy, having affirmative and dependable effect of support and treatment in patients with chronic severe hepatitis.
结论：血浆置换是一种有效的人工肝支持疗法，对慢性重型肝炎有肯定和可靠的辅助支持与治疗作用。
Results The level of serum IL-6 increased gradually and significantly from the group of healthy control to the group of patients with chronic hepatitis B and patients with chronic severe hepatitis B.
结果自正常对照组到慢性乙型肝炎组及慢性重型乙型肝炎组外周血清IL-6水平均依次升高，且各组间比较均具有显著性差异；
To assess the value of the model for end-stage liver disease (MELD) on the short-term prognosis in the patients with chronic liver failure (chronic and severe hepatitis B).
探讨终末期肝病模型(MELD)评分系统对预测慢性重型乙型病毒性肝炎患者短期预后的临床应用价值。
The plasma exchange's efficacy for chronic severe hepatitis patients with underlying liver cirrhosis were lower than those with chronic hepatitis(P<0.01).
在肝硬化基础上发生的重型肝炎患者血浆置换的疗效低于在慢性肝炎基础上发生的重型肝炎（P<0.01）；
The patients with cirrhosis or severe chronic hepatitis have higher nosocomial infectious probability. They have unfavourable prognosis and higher mortality.
结论肝硬化、重度慢性肝炎患者是医院感染的高发人群，预后差，死亡率高。
The united mutations often occurred in patients with severe chronic hepatitis B, and been not related to the viral load.
联合变异株主要见于重度慢性乙型肝炎患者，与血清病毒含量无关。
Objective: To evaluate the application of the Model for End-Stage Liver Disease (MELD) in predicting the short-term prognosis in patients with chronic severe viral hepatitis.
目的：应用MELD(终末期肝病评分模型)评价慢性重型肝炎的近期预后。
Objective To investigate the features of the acute gastric mucosal lesion in patients with chronic severe-type hepatitis by endoscopy.
目的观察慢性重型肝炎患者合并胃黏膜病变的特点。
Conclusions Artificial liver support system is of positive effect for liver function, especially for patients with early and medium-term chronic severe hepatitis, with light side-effect.
结论人工肝对慢性重型肝炎患者的治疗表明，对肝功能有肯定的支持作用，不良反应轻，尤其对早、中期患者治疗效果更好。
Conclusions Artificial liver support system is of positive effect for liver function, especially for patients with early and medium-term chronic severe hepatitis, with light side-effect.
结论人工肝对慢性重型肝炎患者的治疗表明，对肝功能有肯定的支持作用，不良反应轻，尤其对早、中期患者治疗效果更好。
应用推荐